VX17-659-102


Study NameStudy TitleStudy TypeSponsorSponsor Type
VX17-659-102A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)Clinical TrialVertexIndustry Sponsored